{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T22:50:59Z","timestamp":1761519059208,"version":"build-2065373602"},"reference-count":40,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[1997,1,1]],"date-time":"1997-01-01T00:00:00Z","timestamp":852076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[1997,1,1]],"date-time":"1997-01-01T00:00:00Z","timestamp":852076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["aacejournalendocrinepractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrine Practice"],"published-print":{"date-parts":[[1997,1]]},"DOI":"10.4158\/ep.3.1.22","type":"journal-article","created":{"date-parts":[[2013,4,5]],"date-time":"2013-04-05T23:28:31Z","timestamp":1365204511000},"page":"22-26","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Primary Hyperparathyroidism: Diagnosis and Management"],"prefix":"10.1016","volume":"3","author":[{"given":"Aliya","family":"Khan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.4158\/EP.3.1.22_bb0005","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1056\/NEJM198001243020402","article-title":"Primary hyperparathyroidism: incidence, morbidity, and potential economic impact in a community","volume":"302","author":"Heath","year":"1980","journal-title":"N Engl J Med."},{"key":"10.4158\/EP.3.1.22_bb0010","first-page":"94","article-title":"Primary hyperparathyroidism","volume":"69","author":"Diamond","year":"1986","journal-title":"S Afr Med J."},{"key":"10.4158\/EP.3.1.22_bb0015","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0140-6736(87)91906-4","article-title":"Survival and renal function in untreated hypercalcaemia: population-based cohort study with 14 years of follow-up","volume":"1","author":"Palmer","year":"1987","journal-title":"Lancet."},{"issue":"Suppl","key":"10.4158\/EP.3.1.22_bb0020","first-page":"2","article-title":"Epidemiology of primary hyperparathyroidism","volume":"6","author":"Melton","year":"1991","journal-title":"J Bone Miner Res."},{"key":"10.4158\/EP.3.1.22_bb0025","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1001\/archinte.1989.00390040031006","article-title":"Primary hyperparathyroidism: a review of the long-term surgical and nonsurgical morbidities as a basis for a rational approach to treatment","volume":"149","author":"Lafferty","year":"1989","journal-title":"Arch Intern Med."},{"key":"10.4158\/EP.3.1.22_bb0030","doi-asserted-by":"crossref","first-page":"402","DOI":"10.7326\/0003-4819-102-3-402","article-title":"Surgery or no surgery for primary hyperparathyroidism","volume":"102","author":"Bilezikian","year":"1985","journal-title":"Ann Intern Med."},{"key":"10.4158\/EP.3.1.22_bb0035","series-title":"The Parathyroids","first-page":"407","article-title":"Molecular basis of hyperparathyroidism","author":"Arnold","year":"1994"},{"key":"10.4158\/EP.3.1.22_bb0040","first-page":"254","article-title":"Dose-response relationships for radiation-induced hyperparathyroidism","volume":"80","author":"Schneider","year":"1995","journal-title":"J Clin Endocrinol Metab."},{"key":"10.4158\/EP.3.1.22_bb0045","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1056\/NEJM199204303261806","article-title":"Management of acute hypercalcemia","volume":"326","author":"Bilezikian","year":"1992","journal-title":"N Engl J Med."},{"key":"10.4158\/EP.3.1.22_bb0050","unstructured":"Mundy GR. Calcium Homeostasis: Hypercalcemia and Hypocalcemia. 2nd ed. London: Martin Dunitz, 1990: 151-152."},{"key":"10.4158\/EP.3.1.22_bb0055","doi-asserted-by":"crossref","first-page":"365","DOI":"10.7326\/0003-4819-83-3-365","article-title":"Back pain and vertebral crush fractures: an unemphasized mode of presentation for primary hyperparathyroidism","volume":"83","author":"Dauphine","year":"1975","journal-title":"Ann Intern Med."},{"key":"10.4158\/EP.3.1.22_bb0060","series-title":"Clinical Disorders of Bone and Mineral Metabolism","first-page":"200","article-title":"PTH mediated bone loss in primary and secondary hyperparathyroidism","author":"Kleerekoper","year":"1983"},{"issue":"Suppl","key":"10.4158\/EP.3.1.22_bb0065","first-page":"1","article-title":"Primary hyperparathyroidism: clinical and structural findings in 130 cases","volume":"294","author":"Hellstrom","year":"1962","journal-title":"Acta Chir Scand."},{"key":"10.4158\/EP.3.1.22_bb0070","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/0002-9610(83)90416-6","article-title":"Primary hyperparathyroidism in the seventies: a decade of change","volume":"146","author":"Browder","year":"1983","journal-title":"Am J Surg."},{"key":"10.4158\/EP.3.1.22_bb0075","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1016\/S0140-6736(80)91783-3","article-title":"Primary hyperparathyroidism: changes in the pattern of clinical presentation","volume":"1","author":"Mundy","year":"1980","journal-title":"Lancet."},{"key":"10.4158\/EP.3.1.22_bb0080","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1136\/bmj.1.5391.1153","article-title":"Plasma chloride levels in hyperparathyroidism and other hypercalcemic states","volume":"1","author":"Wills","year":"1964","journal-title":"BMJ."},{"key":"10.4158\/EP.3.1.22_bb0085","doi-asserted-by":"crossref","first-page":"511","DOI":"10.7326\/0003-4819-102-4-511","article-title":"Familial benign hypercalcemia (hypocalciuric hypercalcemia)\u2014clinical and pathogenetic studies in 21 families","volume":"102","author":"Law","year":"1985","journal-title":"Ann Intern Med."},{"issue":"6","key":"10.4158\/EP.3.1.22_bb0090","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1210\/jcem-70-6-1489","article-title":"Management of asymptomatic hyperparathyroidism","volume":"70","author":"Potts","year":"1990","journal-title":"J Clin Endocrinol Metab."},{"key":"10.4158\/EP.3.1.22_bb0095","first-page":"991","article-title":"Persistent and recurrent sporadic primary hyperparathyroidism: histopathology, complications, and results of reoperation","volume":"116","author":"Weber","year":"1994","journal-title":"Surgery."},{"key":"10.4158\/EP.3.1.22_bb0100","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1210\/jcem.80.1.7829631","article-title":"Primary hyperparathyroidism: is technetium 99m-sestamibi\/iodine-123 subtraction scanning the best procedure to locate enlarged glands before surgery?","volume":"80","author":"Hindie","year":"1995","journal-title":"J Clin Endocrinol Metab."},{"key":"10.4158\/EP.3.1.22_bb0105","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/S0039-6109(16)46635-1","article-title":"Localization studies in patients with hyperparathyroidism","volume":"75","author":"Mitchell","year":"1995","journal-title":"Surg Clin North Am."},{"key":"10.4158\/EP.3.1.22_bb0110","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/S0039-6060(05)80058-3","article-title":"Parathyroidectomy in primary hyperparathyroidism: preoperative localization and routine biopsy of unaltered glands are not necessary","volume":"117","author":"Oertli","year":"1995","journal-title":"Surgery."},{"key":"10.4158\/EP.3.1.22_bb0115","doi-asserted-by":"crossref","first-page":"593","DOI":"10.7326\/0003-4819-114-7-593","article-title":"Diagnosis and management of asymptomatic primary hyperparathyroidism: Consensus Development Conference statement","volume":"114","author":"Consensus Development Conference Panel","year":"1991","journal-title":"Ann Intern Med."},{"key":"10.4158\/EP.3.1.22_bb0120","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1210\/jcem-56-5-953","article-title":"A detailed evaluation of oral phosphorus therapy in selected patients with primary hyperparathyroidism","volume":"56","author":"Broadus","year":"1983","journal-title":"J Clin Endocrinol Metab."},{"key":"10.4158\/EP.3.1.22_bb0125","doi-asserted-by":"crossref","first-page":"14811485","DOI":"10.1056\/NEJM198606053142304","article-title":"Ethinyl estradiol and norethindrone in the treatment of primary hyperparathyroidism in postmenopausal women","volume":"314","author":"Selby","year":"1986","journal-title":"N Engl J Med."},{"key":"10.4158\/EP.3.1.22_bb0130","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1056\/NEJM198606053142309","article-title":"Is estrogen preferable to surgery for postmenopausal women with primary hyperparathyroidism?","volume":"24","author":"Coe","year":"1986","journal-title":"N Engl J Med."},{"key":"10.4158\/EP.3.1.22_bb0135","doi-asserted-by":"crossref","first-page":"360","DOI":"10.7326\/0003-4819-125-5-199609010-00002","article-title":"Effect of hormone replacement therapy on bone mineral density in postmenopausal women with mild primary hyperparathyroidism: a randomized, controlled trial","volume":"125","author":"Grey","year":"1996","journal-title":"Ann Intern Med"},{"key":"10.4158\/EP.3.1.22_bb0140","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1136\/bmj.1.5689.135","article-title":"Renal effects of calcitonin","volume":"1","author":"Cochran","year":"1970","journal-title":"BMJ."},{"key":"10.4158\/EP.3.1.22_bb0145","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/8756-3282(92)90207-D","article-title":"Comparison of low dose intramuscular and intravenous calcitonin in the treatment of primary hyperparathyroidism","volume":"13","author":"Stone","year":"1992","journal-title":"Bone."},{"key":"10.4158\/EP.3.1.22_bb0150","first-page":"381","article-title":"Results of ultrasonically guided percutaneous ethanol injection into parathyroid adenomas in primary hyperparathyroidism","volume":"129","author":"Verges","year":"1993","journal-title":"Acta Endocrinol."},{"key":"10.4158\/EP.3.1.22_bb0155","first-page":"377","article-title":"Acute change in parathyroid function in primary hyperparathyroidism following ultrasonically guided ethanol injection into solitary parathyroid adenomas","volume":"129","author":"Karstrup","year":"1993","journal-title":"Acta Endocrinol."},{"key":"10.4158\/EP.3.1.22_bb0160","doi-asserted-by":"crossref","first-page":"S153","DOI":"10.1002\/jbmr.5650061431","article-title":"Localization of parathyroid tumors in patients with asymptomatic hyperparathyroidism and no previous surgery","volume":"6","author":"Doppman","year":"1991","journal-title":"J Bone Miner Res."},{"key":"10.4158\/EP.3.1.22_bb0165","doi-asserted-by":"crossref","first-page":"919","DOI":"10.2165\/00003495-199142060-00003","article-title":"Bisphosphonates: pharmacology and use in the treatment of tumour-induced hypercalcemic and metastatic bone disease","volume":"42","author":"Fleisch","year":"1991","journal-title":"Drugs."},{"issue":"Suppl","key":"10.4158\/EP.3.1.22_bb0170","first-page":"69","article-title":"Clodronate in the medical management of hyperparathyroidism","volume":"8","author":"Hamdy","year":"1987","journal-title":"Bone."},{"key":"10.4158\/EP.3.1.22_bb0175","first-page":"1067","article-title":"Acute changes in calcium homeostasis during treatment of primary hyperparathyroidism with residronate","volume":"77","author":"Reasner","year":"1993","journal-title":"J Clin Endocrinol Metab."},{"key":"10.4158\/EP.3.1.22_bb0180","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1111\/j.1365-2265.1990.tb00504.x","article-title":"Regulation of calcium-parathyroid hormone feedback in primary hyperthyroidism: effects of bisphosphonate treatment","volume":"33","author":"Adami","year":"1990","journal-title":"Clin Endocrinol (Oxf)."},{"key":"10.4158\/EP.3.1.22_bb0185","doi-asserted-by":"crossref","first-page":"20632064","DOI":"10.1001\/jama.1983.03330390067035","article-title":"Treatment of hyperparathyroidism with etidronate disodium","volume":"249","author":"Licata","year":"1983","journal-title":"JAMA."},{"key":"10.4158\/EP.3.1.22_bb0190","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1002\/jbmr.5650060915","article-title":"BM 21.0955, a potent new bisphosphonate to inhibit bone resorption","volume":"6","author":"Muhlbauer","year":"1991","journal-title":"J Bone Miner Res."},{"key":"10.4158\/EP.3.1.22_bb0195","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1056\/NEJM199511303332201","article-title":"Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis","volume":"333","author":"Liberman","year":"1995","journal-title":"N Engl J Med."},{"key":"10.4158\/EP.3.1.22_bb0200","first-page":"961","article-title":"Comparative study of alendronate versus etidronate for the treatment of Paget\u2019s disease of bone","volume":"81","author":"Siris","year":"1996","journal-title":"J Clin Endocrinol Metab."}],"container-title":["Endocrine Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X20429362?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X20429362?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/aace.metapress.com\/index\/5U20WHLY65H8J0M9.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T22:16:44Z","timestamp":1761517004000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1530891X20429362"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1997,1]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1997,1]]}},"alternative-id":["S1530891X20429362"],"URL":"https:\/\/doi.org\/10.4158\/ep.3.1.22","relation":{},"ISSN":["1530-891X"],"issn-type":[{"type":"print","value":"1530-891X"}],"subject":[],"published":{"date-parts":[[1997,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Primary Hyperparathyroidism: Diagnosis and Management","name":"articletitle","label":"Article Title"},{"value":"Endocrine Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.4158\/EP.3.1.22","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 1997 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}